The resolution acknowledges the significant impact of rare diseases, which collectively affect millions of Americans, including approximately 750,000 residents of Washington state. It highlights the challenges faced by individuals and families dealing with these conditions, such as delays in diagnosis, difficulties in accessing medical expertise, and limited treatment options. Despite the approval of drugs for over 880 rare disease indications by the Food and Drug Administration, many patients still lack effective treatments. The resolution also notes the burden placed on families to fund research and raise awareness for less-known rare diseases.

Furthermore, the resolution commends the efforts to find cures for rare diseases and encourages Washingtonians to support those affected by these conditions. It recognizes the role of the Orphan Drug Act in promoting the development of treatments and acknowledges the contributions of Washington's academic institutions and biotech companies in this field. Ultimately, the resolution calls for compassion and commitment to scientific discovery to improve the lives of those impacted by rare diseases.